Innate Pharma Stock Cycle Indicators Hilbert Transform Dominant Cycle Period

IPHYF Stock  USD 1.28  0.00  0.00%   
Innate Pharma cycle indicators tool provides the execution environment for running the Hilbert Transform Dominant Cycle Period indicator and other technical functions against Innate Pharma. Innate Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Dominant Cycle Period indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of Innate Pharma price series.

Indicator
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The Hilbert Transform - Dominant Cycle Period indicator is used to generate in-phase and quadrature components of Innate Pharma price series in order to analyze variations of the instantaneous cycles.

Innate Pharma Technical Analysis Modules

Most technical analysis of Innate Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Innate from various momentum indicators to cycle indicators. When you analyze Innate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Innate Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Innate Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innate Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Innate Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innate Pharma's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Innate Pharma's intrinsic value. In addition to deriving basic predictive indicators for Innate Pharma, we also check how macroeconomic factors affect Innate Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Innate Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.286.70
Details
Intrinsic
Valuation
LowRealHigh
0.081.546.96
Details
Naive
Forecast
LowNextHigh
0.031.506.92
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.731.682.64
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Information and Resources on Investing in Innate Pink Sheet

When determining whether Innate Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innate Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innate Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innate Pharma Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innate Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
For more detail on how to invest in Innate Pink Sheet please use our How to Invest in Innate Pharma guide.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Please note, there is a significant difference between Innate Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innate Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innate Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.